(Q33894498)

English

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

anti-retroviral agent

0 references

United States of America

0 references

1 reference

based on heuristic

inferred from title

opportunistic infection

1 reference

based on heuristic

inferred from title

Mary Lou Lindegren

6

object named as

M L Lindegren

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

J E Kaplan

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

D Hanson

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

M S Dworkin

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

T Frederick

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J Bertolli

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

S Holmberg

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J L Jones

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

30 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

S5-14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Natural history of opportunistic disease in an HIV-infected urban clinical cohort

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991-1996.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Gender differences in reported AIDS-indicative diagnoses

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Racial differences in the use of drug therapy for HIV disease in an urban community

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33894498&oldid=1983509619"